CSIMarket
 


Regeneron Pharmaceuticals Inc   (REGN)
Other Ticker:  
 


Regeneron Pharmaceuticals Inc 's Free Cash Flow Margin by quarter

Trends, Rankings, Statistics



REGN Free Cash Flow Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 0.58 % 14.53 % 10.53 % 6.64 % -31.05 %
Seq. Revenue Change 2.13 % 6.48 % -0.13 % -7.39 % 16.29 %
Revenue In Millions $3,434.30 $3,362.70 $3,158.10 $3,162.10 $3,414.40
Free Cash Flow Margin 31.73 % 33.14 % 32.37 % 43.25 % 50.37 %
Free Cash Flow Margin Total Ranking # 643 # 826 # 737 # 464 # 513
Free Cash Flow In Millions $1,089.70 $1,114.30 $1,022.40 $1,367.60 $1,719.90
Y / Y Free Cash Flow Change -36.64 % 77.18 % 81.15 % -34.93 % -27.51 %
Seq. Free Cash Flow Change -2.21 % 8.99 % -25.24 % -20.48 % 173.48 %


Commenting fourth Quarter 2023 Free Cash Flow Margin
Company's Free Cash Flow Margin decreased in IV. Quarter to 31.73 %, below company's average Free Cash Flow Margin.

Observing fourth quarter 2023 results within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Free Cash Flow Margin. While Free Cash Flow Margin total ranking has impoved so far to 643, from total ranking in previous quarter at 826.

REGN's Free Cash Flow Margin fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 20
Healthcare Sector # 33
Overall # 642

Free Cash Flow Margin Statistics
High Average Low
98.86 % 32.32 % 0.37 %
(Sep 30 2021)   (Jun 30 2015)




Other Free Cash Flow Margin Profitability Ratios
REGN's Cumulative Free Cash Flow Margin
Major Pharmaceutical Preparations Industry Free Cash Flow Margin Trends and Statistics
Healthcare Sector Free Cash Flow Margin Statistics
Free Cash Flow Margin Profitability Trends for overall market
REGN's Free Cash Flow Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Margin
Lowest Ranking Free Cash Flow Margin
Free Cash Flow Margin Profit Margin for REGN's Competitors
Free Cash Flow Margin Profit Margin for Regeneron Pharmaceuticals Inc 's Suppliers
Free Cash Flow Margin Profit Margin for REGN's Customers

You may also want to know
REGN's Annual Growth Rates REGN's Profitability Ratios REGN's Asset Turnover Ratio REGN's Dividend Growth
REGN's Roe REGN's Valuation Ratios REGN's Financial Strength Ratios REGN's Free Cash Flow Growth
REGN's Roa REGN's Inventory Turnover Ratio REGN's Growth Rates REGN's Dividend Comparisons


Companies with similar Free Cash Flow Margin in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Free Cash Flow MarginDec 31 2023 MRQ Free Cash FlowDec 31 2023 MRQ Revenue
Zymeworks Inc   82.44 %$ 13.954 $ 16.926 
Siga Technologies Inc  67.85 %$ 79.032 $ 116.481 
Johnson and Johnson  58.11 %$ 7,863.000 $ 13,532.000 
Astrazeneca Plc  52.69 %$ 24,137.000 $ 45,811.000 
Catalyst Pharmaceuticals Inc   50.33 %$ 55.648 $ 110.568 
Harmony Biosciences Holdings inc   45.51 %$ 76.665 $ 168.472 
Zoetis Inc   40.53 %$ 897.000 $ 2,213.000 
Bristol myers Squibb Company  37.05 %$ 4,252.000 $ 11,477.000 
Pfizer Inc  36.78 %$ 5,240.000 $ 14,248.000 
Optinose Inc   34.78 %$ 6.909 $ 19.864 
Ani Pharmaceuticals Inc  33.98 %$ 44.740 $ 131.654 
Abbvie inc   33.24 %$ 4,753.000 $ 14,301.000 
Aurinia Pharmaceuticals Inc   31.74 %$ 14.312 $ 45.095 
Regeneron Pharmaceuticals Inc   31.73 %$ 1,089.700 $ 3,434.300 
Novartis Ag  30.99 %$ 14,458.000 $ 46,660.000 
Ironwood Pharmaceuticals inc   30.48 %$ 35.834 $ 117.553 
Abbott Laboratories  29.67 %$ 3,038.000 $ 10,241.000 
Protagonist Therapeutics inc   28.27 %$ 16.960 $ 60.000 
Teva Pharmaceutical Industries Limited  26.57 %$ 1,184.000 $ 4,456.000 
Hutchmed china Limited  26.16 %$ 219.258 $ 837.999 
Prestige Consumer Healthcare Inc   25.35 %$ 71.472 $ 281.938 
Organon and Co   24.84 %$ 397.000 $ 1,598.000 
United Therapeutics Corporation  24.52 %$ 150.700 $ 614.700 
Endo International Plc  23.12 %$ 115.057 $ 497.734 
Sanofi  22.09 %$ 11,488.960 $ 52,016.960 
Amneal Pharmaceuticals Inc   21.98 %$ 135.823 $ 617.827 
Perrigo Company Plc  18.02 %$ 208.700 $ 1,158.400 
Assertio Holdings inc   17.30 %$ 5.707 $ 32.985 
Xeris Biopharma Holdings Inc   16.83 %$ 7.471 $ 44.390 
Jazz Pharmaceuticals Plc  16.54 %$ 167.339 $ 1,011.935 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com